Others lose weight using GLP-1 injections but then lose insurance coverage, while some are skeptical of GLP-1s but could use dissolvable tablets as a ramp-on product toward branded GLP-1s
Affiliate disclosure: The Peptide Catalog earns a commission on purchases made through the vendor links below
They also explain why the regulatory landscape became so contentious
Developed initially as antidiabetic agents, these medications are now at the forefront of interest in physician-monitored, non-surgical weight management protocols
Mechanism of Action: GLP-1 receptor agonists work through multiple physiological pathways: Central appetite suppression : These medications cross the blood-brain barrier and activate GLP-1 receptors in the hypothalamus and brainstem, reducing hunger signals and increasing satiety Gastric emptying delay : By slowing stomach emptying, patients experience prolonged fullness after meals Insulin secretion enhancement : Glucose-dependent insulin release improves glycemic control Glucagon suppression : Reduced glucagon secretion decreases hepatic glucose production Tirzepatide offers dual agonism at both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially providing enhanced weight loss efficacy compared to single-agonist medications
Legitimate cheap compounded tirzepatide exists, but there is a floor below which quality cannot be maintained